Abstract
Health research for progress in the control and conquest of disease afflicting man is unquestionable. Concerns arise when motives other than the advancement of scientific knowledge and benefit for individuals and society are the driving force behind clinical trials. These conflicts of interests become even more pronounced when dealing with populations rendered vulnerable by virtue of poverty and ignorance. South Asia with its teeming millions represents one such region. This essay examines the reasons that make this population vulnerable to exploitation. Informed consent in the process of research is an area where such conflicts are prone to arise. In order to ensure that conflicting interests of researchers and funding agencies are kept in check, the processes of informed consent and ethical review of research need to be strengthened. Suggestions are put forward to modify the consent process to match the needs of South Asia and to strengthen the ethical review process for safeguarding the rights of the study subjects. But perhaps the most important safeguard against exploitation is the virtuous researcher himself with noble intentions.
Similar content being viewed by others
References
Benetar S.R. (2000) Avoiding exploitation in clinical research. Camb Q Health Ethics (Fall) 9(4): 262–265.
Angell M. (2000) Investigators responsibilities for human subjects in developing countries. N Engl J Med 342: 967–969.
Benatar S.R. & Singer P.A. (2000) A new look at international ethics research. BMJ 321: 824–826.
Angell M. (1997) The ethics of clinical research in the third world. N Engl J Med 337: 847–849.
The ethics of research related to healthcare in developing countries. The Nuffield Council on Bioethics, April 2002, table 5.1, p. 61.
Shapiro H.T. & Meslin E.M. (2001) Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 345(2): 139–142.
The State Of The Worlds Children 2001, United Nations Children’s Fund, in Basic indicator: 87–101.
Smith S.L. & Blake K. (2002) Community entry in entering rural focus groups: process, legitimacy and lessons learnt. J Rural Health (winter)18(1): 118–123.
Hewlett S. (1996) Consent to clinical research-adequately voluntary or substantially influenced. Journal of Medical Ethics 22: 232–237.
Thompson D.F. (1993) Understanding financial conflicts of interest. N Engl J Med 329(8): 573–576.
Lind S.E. (1990) Finders fee for research subjects. N Engl J Med 323: 192–195.
Barry M. (1988) Ethical considerations on human investigation in developing countries. N Engl J Med 319: 1083–1086.
The ethics of clinical research in developing countries. The Nuffield Council on Bioethics, Oct 1999, 13.
Ethical Guidelines for Biomedical Research on Human Subjects, 2000, The Indian Council of Medical Research.
World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000, World Medical Association, Ferney-Voltaire, France.
International Ethical Guidelines for Biomedical Research Involving Human Subjects (1993) Council for International Organizations of Medical Sciences (CIOMS), Geneva.
Hoey J. & Todkill A.M. (2002) Complaints and conundrums: an ombudsman-ethicist for CMAJ. CMAJ (May 14) 16(10).
Umar bin Al-Khattab, Sahih Bukhari. Vol 1, book 1, no 1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jafarey, A.M. Conflict of interest issues in informed consent for research on human subjects: A South Asian perspective. SCI ENG ETHICS 8, 353–362 (2002). https://doi.org/10.1007/s11948-002-0055-9
Issue Date:
DOI: https://doi.org/10.1007/s11948-002-0055-9